A prospective evaluation of left ventricular remodeling after inaugural anterior myocardial infarction as a function of gene polymorphisms in the renin-angiotensin-aldosterone, adrenergic, and metalloproteinase systems

American Heart Journal

Volumn 153, Issue 4, 2007, Pages 641-648

  Bauters, Christophe ^a,b,c   Lamblin, Nicolas ^a,c   Ennezat, Pierre V ^a   Mycinski, Christophe ^d   Tricot, Olivier ^e   Nugue, Olivier ^f   Segrestin, Benoit ^g   Hannebicque, Gery ^h   Agraou, Benaissa ⁱ   Polge, Anne Sophie ^a   de Groote, Pascal ^a   Helbecque, Nicole ^c   Amouyel, Philippe ^a,b,c  

^a LILLE UNIVERSITY HOSPITAL   (France)

^b UNIV LILLE   (France)

^c INSERM   (France)

^d Service de Pneumologie   (France)

^e Centre Hospitalier de Dunkerque   (France)

^f Centre Hospitalier de Boulogne   (France)

^g Centre Hospitalier de St Omer   (France)

^h Centre Hospitalier d'Arras   (France)

ⁱ CENTRE HOSPITALIER DE VALENCIENNES   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ALDOSTERONE SYNTHASE; ALPHA 2C ADRENERGIC RECEPTOR; ANGIOTENSINOGEN; BETA 1 ADRENERGIC RECEPTOR; BETA 2 ADRENERGIC RECEPTOR; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; GELATINASE A; GELATINASE B; GLYCINE; INTERSTITIAL COLLAGENASE; METALLOPROTEINASE; SERINE; THREONINE;

ADRENERGIC SYSTEM; ADULT; ARTICLE; CONTROLLED STUDY; DNA POLYMORPHISM; ECHOCARDIOGRAPHY; FEMALE; FOLLOW UP; GENOTYPE; HEART INFARCTION; HEART VENTRICLE REMODELING; HEART VENTRICLE VOLUME; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM;

EID: 33947310816     PISSN: 00028703     EISSN: 10976744     Source Type: Journal    
DOI: 10.1016/j.ahj.2007.01.009     Document Type: Article

References (34)

1. Pfeffer M.A., and Braunwald E. Ventricular remodeling after myocardial infarction. Experimental observations and clinical implications. Circulation 81 (1990) 1161-1172
2. St John Sutton M., Pfeffer M.A., Plappert T., et al. Quantitative two-dimensional echocardiographic measurements are major predictors of adverse cardiovascular events after acute myocardial infarction. The protective effects of captopril. Circulation 89 (1994) 68-75
3. Gaudron P., Eilles C., Kugler I., et al. Progressive left ventricular dysfunction and remodeling after myocardial infarction. Potential mechanisms and early predictors. Circulation 87 (1993) 755-763
4. Warren S.E., Royal H.D., Markis J.E., et al. Time course of left ventricular dilation after myocardial infarction: influence of infarct-related artery and success of coronary thrombolysis. J Am Coll Cardiol 11 (1988) 12-19
5. Pinto Y.M., van Gilst W.H., Kingma J.H., et al. Deletion-type allele of the angiotensin-converting enzyme gene is associated with progressive ventricular dilation after anterior myocardial infarction. Captopril and Thrombolysis Study Investigators. J Am Coll Cardiol 25 (1995) 1622-1626
6. Ohmichi N., Iwai N., Maeda K., et al. Genetic basis of left ventricular remodeling after myocardial infarction. Int J Cardiol 53 (1996) 265-272
7. Zee R.Y., Solomon S.D., Ajani U.A., et al. A prospective evaluation of the angiotensin-converting enzyme D/I polymorphism and left ventricular remodeling in the 'Healing and Early Afterload Reducing Therapy' study. Clin Genet 61 (2002) 21-25
8. Martin T.N., Penney D.E., Smith J.A., et al. Matrix metalloproteinase-1 promoter polymorphisms and changes in left ventricular volume following acute myocardial infarction. Am J Cardiol 94 (2004) 1044-1046
9. Amant C., Hamon M., Bauters C., et al. The angiotensin II type 1 receptor gene polymorphism is associated with coronary artery vasoconstriction. J Am Coll Cardiol 29 (1997) 486-490
10. Lamblin N., Bauters C., Hermant X., et al. Polymorphisms in the promoter regions of MMP-2, MMP-3, MMP-9 and MMP-12 genes as determinants of aneurysmal coronary artery disease. J Am Coll Cardiol 40 (2002) 43-48
11. de Groote P., Helbecque N., Lamblin N., et al. Association between beta-1 and beta-2 adrenergic receptor gene polymorphisms and the response to beta-blockade in patients with stable congestive heart failure. Pharmacogenet Genomics 15 (2005) 137-142
12. Savoye C., Equine O., Tricot O., et al. Left ventricular remodeling after anterior wall acute myocardial infarction in modern clinical practice (from the REmodelage VEntriculaire [REVE] study group). Am J Cardiol 98 (2006) 1144-1149
13. Pfeffer M.A., Braunwald E., Moye L.A., et al. Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial. The SAVE Investigators. N Engl J Med 327 (1992) 669-677
14. Pfeffer M.A., McMurray J.J., Velazquez E.J., et al. Valsartan, captopril, or both in myocardial infarction complicated by heart failure, left ventricular dysfunction, or both. N Engl J Med 349 (2003) 1893-1906
15. Hayashi M., Tsutamoto T., Wada A., et al. Immediate administration of mineralocorticoid receptor antagonist spironolactone prevents post-infarct left ventricular remodeling associated with suppression of a marker of myocardial collagen synthesis in patients with first anterior acute myocardial infarction. Circulation 107 (2003) 2559-2565
16. Rigat B., Hubert C., Alhenc-Gelas F., et al. An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels. J Clin Invest 86 (1990) 1343-1346
17. van Geel P.P., Pinto Y.M., Voors A.A., et al. Angiotensin II type 1 receptor A1166C gene polymorphism is associated with an increased response to angiotensin II in human arteries. Hypertension 35 (2000) 717-721
18. Bloem L.J., Manatunga A.K., Tewksbury D.A., et al. The serum angiotensinogen concentration and variants of the angiotensinogen gene in white and black children. J Clin Invest 95 (1995) 948-953
19. Pojoga L., Gautier S., Blanc H., et al. Genetic determination of plasma aldosterone levels in essential hypertension. Am J Hypertens 11 (1998) 856-860
20. Hengstenberg C., Holmer S.R., Mayer B., et al. Evaluation of the aldosterone synthase (CYP11B2) gene polymorphism in patients with myocardial infarction. Hypertension 35 (2000) 704-709
21. Freemantle N., Cleland J., Young P., et al. beta blockade after myocardial infarction: systematic review and meta regression analysis. BMJ 318 (1999) 1730-1737
22. Doughty R.N., Whalley G.A., Walsh H.A., et al. Effects of carvedilol on left ventricular remodeling after acute myocardial infarction: the CAPRICORN Echo Substudy. Circulation 109 (2004) 201-206
23. Levin M.C., Marullo S., Muntaner O., et al. The myocardium-protective Gly-49 variant of the beta 1-adrenergic receptor exhibits constitutive activity and increased desensitization and down-regulation. J Biol Chem 277 (2002) 30429-30435
24. Dishy V., Sofowora G.G., Xie H.G., et al. The effect of common polymorphisms of the beta2-adrenergic receptor on agonist-mediated vascular desensitization. N Engl J Med 345 (2001) 1030-1035
25. Mason D.A., Moore J.D., Green S.A., et al. A gain-of-function polymorphism in a G-protein coupling domain of the human beta1-adrenergic receptor. J Biol Chem 274 (1999) 12670-12674
26. Green S.A., Cole G., Jacinto M., et al. A polymorphism of the human beta 2-adrenergic receptor within the fourth transmembrane domain alters ligand binding and functional properties of the receptor. J Biol Chem 268 (1993) 23116-23121
27. Small K.M., Forbes S.L., Rahman F.F., et al. A four amino acid deletion polymorphism in the third intracellular loop of the human alpha 2C-adrenergic receptor confers impaired coupling to multiple effectors. J Biol Chem 275 (2000) 23059-23064
28. Ye S. Influence of matrix metalloproteinase genotype on cardiovascular disease susceptibility and outcome. Cardiovasc Res 69 (2006) 636-645
29. Rutter J.L., Mitchell T.I., Buttice G., et al. A single nucleotide polymorphism in the matrix metalloproteinase-1 promoter creates an Ets binding site and augments transcription. Cancer Res 58 (1998) 5321-5325
30. Price S.J., Greaves D.R., and Watkins H. Identification of novel, functional genetic variants in the human matrix metalloproteinase-2 gene: role of Sp1 in allele-specific transcriptional regulation. J Biol Chem 276 (2001) 7549-7558
31. Ye S., Eriksson P., Hamsten A., et al. Progression of coronary atherosclerosis is associated with a common genetic variant of the human stromelysin-1 promoter which results in reduced gene expression. J Biol Chem 271 (1996) 13055-13060
32. Zhang B., Ye S., Herrmann S.M., et al. Functional polymorphism in the regulatory region of gelatinase B gene in relation to severity of coronary atherosclerosis. Circulation 99 (1999) 1788-1794
33. Medley T.L., Kingwell B.A., Gatzka C.D., et al. Matrix metalloproteinase-3 genotype contributes to age-related aortic stiffening through modulation of gene and protein expression. Circ Res 92 (2003) 1254-1261
34. Medley T.L., Cole T.J., Dart A.M., et al. Matrix metalloproteinase-9 genotype influences large artery stiffness through effects on aortic gene and protein expression. Arterioscler Thromb Vasc Biol 24 (2004) 1479-1484